Hi there, this is Gabija H.Yang from Guangdong, China. I’m currently pursuing my Master’s degree in Guangzhou, expected to graduate in June 2025.
Since 2022, I’ve been studying under Prof. Feng Lu at the Department of Plastic and Reconstructive Surgery, Nanfang Hospital, Southern Medical University. Lu’s lab is one of the earliest adipose medicine teams in China. My research focuses on using adipose acellular matrix (AAM) to explore vascularization mechanisms in natural biomaterials, particularly fascia-mediated biomaterial vascularization.
Additionally, before joining Professor Lu’s lab, I conducted two years of anatomical research under the guidance of Prof. Jingxing Dai. My work mainly focused on the anatomy of (1) facial muscles and blood vessels and (2) foot ligaments. The first aimed to improve injection safety in plastic surgery by reducing risks in facial danger zones, while the second provided anatomical and biomechanical insights for the reconstruction of ATFL and combined ATFL-CFL sprains.
You can find my CV and email here. If you are interested in my work, please feel free to drop me an email.❤️
",
which does not match the baseurl
("
") configured in _config.yml
.
baseurl
in _config.yml
to "
".
") does not match your GitHub username.
".
If the current repository name is intended, you can ignore this message by removing "{% include widgets/url_debug_message.html %}
" in index.html
.
Han Yang*, Sousan Cheong*, Yunfan He, Feng Lu (* equal contribution)
Stem Cell Research & Therapy 2023 Review
Systemic sclerosis (SSc) and sclerodermatous GVHD are autoimmune diseases characterized by severe skin fibrosis due to immune dysfunction. Mesenchymal stem cell (MSC)-based therapies show promise in regulating the immune system, reducing oxidative stress, and inhibiting fibrosis. This review focuses on the role of MSC therapies in treating SSc and Scl-GVHD through these mechanisms.
Han Yang*, Sousan Cheong*, Yunfan He, Feng Lu (* equal contribution)
Stem Cell Research & Therapy 2023 Review
Systemic sclerosis (SSc) and sclerodermatous GVHD are autoimmune diseases characterized by severe skin fibrosis due to immune dysfunction. Mesenchymal stem cell (MSC)-based therapies show promise in regulating the immune system, reducing oxidative stress, and inhibiting fibrosis. This review focuses on the role of MSC therapies in treating SSc and Scl-GVHD through these mechanisms.
Han Yang*, Minghao Su*, Zhimin Chen*, Rongmei Qu, Zhirong Yuan, Jiajie Yuan, Shanli He, Zeyu Li, Chang Liu, Zhaoming Xiao, Haibin Liang, Jun Ouyang, Jingxing Dai (* equal contribution)
Orthopaedic Journal of Sports Medicine 2021 Article
This study analyzed the anatomy of the anterior talofibular ligament (ATFL) and calcaneofibular ligament (CFL) in 66 ankle specimens. It found significant variability in the size and shape of the ATFL, while the angle between the ATFL and CFL remained consistent. Most CFLs attached anterior to the tip of the fibula, rather than directly at the tip. These findings provide essential anatomical data to improve surgical treatment of lateral ankle ligament injuries.
Han Yang*, Minghao Su*, Zhimin Chen*, Rongmei Qu, Zhirong Yuan, Jiajie Yuan, Shanli He, Zeyu Li, Chang Liu, Zhaoming Xiao, Haibin Liang, Jun Ouyang, Jingxing Dai (* equal contribution)
Orthopaedic Journal of Sports Medicine 2021 Article
This study analyzed the anatomy of the anterior talofibular ligament (ATFL) and calcaneofibular ligament (CFL) in 66 ankle specimens. It found significant variability in the size and shape of the ATFL, while the angle between the ATFL and CFL remained consistent. Most CFLs attached anterior to the tip of the fibula, rather than directly at the tip. These findings provide essential anatomical data to improve surgical treatment of lateral ankle ligament injuries.